Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tove Eneljung"'
Autor:
Sara Tengvall, Tove Eneljung, Pernilla Jirholt, Olof Turesson, Kajsa Wing, Rikard Holmdahl, Jan Kihlberg, Anna Stern, Inga-Lill Mårtensson, Louise Henningsson, Kenth Gustafsson, Inger Gjertsson
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154630 (2016)
Here, we investigate induction of immunological tolerance by lentiviral based gene therapy in a mouse model of rheumatoid arthritis, collagen II-induced arthritis (CIA). Targeting the expression of the collagen type II (CII) to antigen presenting cel
Externí odkaz:
https://doaj.org/article/18108702b4af416fa7887cf88191d827
Publikováno v:
Nutrients, Vol 10, Iss 4, p 481 (2018)
Rheumatoid Arthritis (RA) is a chronic inflammatory disease. This study evaluates the effect of blue mussel intake on disease activity and quality of life in women with RA. Thirty-nine women with established RA and a disease activity score 28 (DAS28)
Externí odkaz:
https://doaj.org/article/92a09c7db11541ed8f3d8e6b6fee4a5b
Autor:
Tove Eneljung, Sara Tengvall, Pernilla Jirholt, Louise Henningsson, Rikard Holmdahl, Kenth Gustafsson, Inger Gjertsson
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Reestablishment of tolerance induction in rheumatoid arthritis (RA) would be an optimal treatment with few, if any, side effects. However, to develop such a treatment further insights in the immunological mechanisms governing tolerance are needed. We
Externí odkaz:
https://doaj.org/article/661f439371624f62a479be1b6729193f
Autor:
Louise Henningsson, Tove Eneljung, Pernilla Jirholt, Sara Tengvall, Ulf Lidberg, Wim B van den Berg, Fons A van de Loo, Inger Gjertsson
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49731 (2012)
Rheumatoid arthritis (RA) is a chronic destructive autoimmune disease characterised by periods of flare and remission. Today's treatment is based on continuous immunosuppression irrespective of the patient's inflammatory status. When the disease is i
Externí odkaz:
https://doaj.org/article/78593b0e54b94fc6a8931f498b1b8e2b
Publikováno v:
Nutrients; Volume 10; Issue 4; Pages: 481
Rheumatoid Arthritis (RA) is a chronic inflammatory disease. This study evaluates the effect of blue mussel intake on disease activity and quality of life in women with RA. Thirty-nine women with established RA and a disease activity score 28 (DAS28)
Autor:
Tiina Kelkka, Margareta Verdrengh, Bo Nilson, Brahm H. Segal, Melissa J. Grimm, Ing Marie Jonsson, Angela Pizzolla, Inger Gjertsson, Rikard Holmdahl, Malin Hultqvist, Tove Eneljung
Publikováno v:
The Journal of Immunology. 188:5003-5011
Chronic granulomatous disease (CGD) is an inherited disorder characterized by recurrent life-threatening bacterial and fungal infections. CGD results from defective production of reactive oxygen species by phagocytes caused by mutations in genes enco
Autor:
Martin Adiels, Silvia Bulfone-Paus, Catharina Lindholm, Pernilla Jirholt, Tove Eneljung, Louise Henningsson, Yalda Rahpeymai Bogestål, Inger Gjertsson, Iain B. McInnes, Ulf H. Lerner
Publikováno v:
Journal of Infectious Diseases. 206:687-696
Background. Staphylococcus aureus arthritis causes severe and rapid joint damage despite antibiotics. Thus, there is a need to identify new treatment targets in addition to antibiotics. Lately, interleukin 15 (IL-15) has been implicated both in osteo
Autor:
Rikard Holmdahl, Sara Tengvall, Tove Eneljung, Pernilla Jirholt, Louise Henningsson, Inger Gjertsson, Kenth Gustafsson
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Clinical and Developmental Immunology
Clinical and Developmental Immunology
Reestablishment of tolerance induction in rheumatoid arthritis (RA) would be an optimal treatment with few, if any, side effects. However, to develop such a treatment further insights in the immunological mechanisms governing tolerance are needed. We
Autor:
Tove Eneljung, Inger Gjertsson, Catharina Lindholm, Anders Lindén, Pernilla Jirholt, Yoichiro Iwakura, Louise Henningsson, Elin Silverpil
Staphylococcus aureusis one of the dominant pathogens that induce septic arthritis in immunocompromised hosts, e.g., patients suffering from rheumatoid arthritis treated with immunosuppressive drugs.S. aureus-induced arthritis leads to severe joint d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d7f57771038b694b8d516eaec72a8dc
https://europepmc.org/articles/PMC2937437/
https://europepmc.org/articles/PMC2937437/
Autor:
Kenth Gustafsson, Inger Gjertsson, Sara Tengvall, Tove Eneljung, I.-L. Mårtensson, Anna Stern, Pernilla Jirholt
Publikováno v:
Annals of the Rheumatic Diseases. 72:A115.2-A115
Background Rheumatoid arthritis (RA) is a destructive autoimmune disease. Today’s treatment is associated with side effects and only suppresses the disease. A safe and effective therapy would be to re-establish tolerance, i.e. the ability to recogn